Micrima: Developing technology for breast cancer screening
A new breast cancer screening method in the future.
Micrima is a Bristol based diagnostic imaging company founded in 2006. Micrima has developed the MARIA® breast cancer screening system. This breast imaging system uses harmless radio-waves to detect breast cancer, unlike mammography that uses ionising radiation. MARIA® also requires no breast compression so is painless for women. It is a whole breast method of imaging compared to some modalities that use a handheld probe. With a handheld system, the operator needs to know where to look for a lesion. It has proven more effective than current imaging methods, particularly in dense tissue. MARIA® has been trialled in over 400 women in the United Kingdom. Further trials are taking place at leading European centres. Currently, MARIA® is being used in symptomatic clinics, it is hoped eventually this will be a viable alternative to mammography in breast screening.
Clinical poster and presentation
Micrima is pleased to have had a poster at the EUSOBI scientific meeting this year and the …
Micrima’s latest grant funded project
Reaching a final diagnosis for Breast cancer is a complex process with many steps. Despite the diagnostic performance …